Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Randomised Double-blind Placebo-controlled Dose-finding Study of Darbepoetin alfa for Chemotherapy-induced Anemia in Paediatric Solid Tumours
2008-001721-34Phase 2Completed
- Sponsor
- Amgen
- Start
- Feb 2009
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chemotherapy-induced anaemia (CIA) comparing Darbepoetin alfa with Placebo (2 arms). Primary endpoint: Change in hemoglobin from baseline to End of Treatment Period. Started Feb 2009; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
chemotherapy-induced anaemia (CIA)
Beyond the preview
Go deeper on 2008-001721-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001721-34.